These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10591185)

  • 1. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.
    Chapman TL; Heikeman AP; Bjorkman PJ
    Immunity; 1999 Nov; 11(5):603-13. PubMed ID: 10591185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.
    Cosman D; Fanger N; Borges L; Kubin M; Chin W; Peterson L; Hsu ML
    Immunity; 1997 Aug; 7(2):273-82. PubMed ID: 9285411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.
    Willcox BE; Thomas LM; Chapman TL; Heikema AP; West AP; Bjorkman PJ
    BMC Struct Biol; 2002 Oct; 2():6. PubMed ID: 12390682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.
    Cerboni C; Achour A; Wärnmark A; Mousavi-Jazi M; Sandalova T; Hsu ML; Cosman D; Kärre K; Carbone E
    Eur J Immunol; 2006 Mar; 36(3):732-41. PubMed ID: 16479538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones.
    Vitale M; Castriconi R; Parolini S; Pende D; Hsu ML; Moretta L; Cosman D; Moretta A
    Int Immunol; 1999 Jan; 11(1):29-35. PubMed ID: 10050671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1.
    Wagner CS; Rölle A; Cosman D; Ljunggren HG; Berndt KD; Achour A
    J Mol Biol; 2007 Oct; 373(3):695-705. PubMed ID: 17869268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cis association of leukocyte Ig-like receptor 1 with MHC class I modulates accessibility to antibodies and HCMV UL18.
    Li NL; Fu L; Uchtenhagen H; Achour A; Burshtyn DN
    Eur J Immunol; 2013 Apr; 43(4):1042-52. PubMed ID: 23348966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers.
    Cosman D; Fanger N; Borges L
    Immunol Rev; 1999 Apr; 168():177-85. PubMed ID: 10399074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor.
    Yang Z; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10095-100. PubMed ID: 18632577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.
    Prod'homme V; Griffin C; Aicheler RJ; Wang EC; McSharry BP; Rickards CR; Stanton RJ; Borysiewicz LK; López-Botet M; Wilkinson GW; Tomasec P
    J Immunol; 2007 Apr; 178(7):4473-81. PubMed ID: 17372005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2).
    Chapman TL; Heikema AP; West AP; Bjorkman PJ
    Immunity; 2000 Nov; 13(5):727-36. PubMed ID: 11114384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection.
    Wagner CS; Riise GC; Bergström T; Kärre K; Carbone E; Berg L
    J Immunol; 2007 Mar; 178(6):3536-43. PubMed ID: 17339449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells.
    Saverino D; Ghiotto F; Merlo A; Bruno S; Battini L; Occhino M; Maffei M; Tenca C; Pileri S; Baldi L; Fabbi M; Bachi A; De Santanna A; Grossi CE; Ciccone E
    J Immunol; 2004 May; 172(9):5629-37. PubMed ID: 15100307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor.
    Willcox BE; Thomas LM; Bjorkman PJ
    Nat Immunol; 2003 Sep; 4(9):913-9. PubMed ID: 12897781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of MHC class I recognition by natural killer cell receptors.
    Sawicki MW; Dimasi N; Natarajan K; Wang J; Margulies DH; Mariuzza RA
    Immunol Rev; 2001 Jun; 181():52-65. PubMed ID: 11513152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.
    Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K
    J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.
    Valés-Gómez M; Shiroishi M; Maenaka K; Reyburn HT
    J Virol; 2005 Feb; 79(4):2251-60. PubMed ID: 15681427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor.
    Occhino M; Ghiotto F; Soro S; Mortarino M; Bosi S; Maffei M; Bruno S; Nardini M; Figini M; Tramontano A; Ciccone E
    J Immunol; 2008 Jan; 180(2):957-68. PubMed ID: 18178836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18.
    Chen KC; Stanton RJ; Banat JJ; Wills MR
    J Virol; 2016 Jan; 90(6):3123-37. PubMed ID: 26739048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paired inhibitory and triggering NK cell receptors for HLA class I molecules.
    López-Botet M; Bellón T; Llano M; Navarro F; García P; de Miguel M
    Hum Immunol; 2000 Jan; 61(1):7-17. PubMed ID: 10658973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.